In summary, we have shown that CD11b+ cells exposed to pre-patent schistosome infection are impaired in their ability to stimulate CD4+ T cells and that this may contribute to an overall reduction of T cell responsiveness during pre-patent infection. This evidence concerns the gene CD4 and infection.